Healthline
June 14, 2025
Share on PinterestThe Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United […]
June 13, 2025
Share on PinterestA large study found that dementia risk was lowest in the Mid-Atlantic region and highest in the Southeast. Getty Images A large study of […]
June 11, 2025
Share on PinterestA healthy, well-balanced diet is key to successful, sustained weight management. Photography by Aya Brackett Calorie-restricted dieting is linked to an increased risk of […]
June 11, 2025
Share on PinterestA new study suggests TikTok skin care videos catering to young girls contain harsh active ingredients, which may cause irritation and allergies. Filippo Bacci/Getty […]
Medscape
June 14, 2025
BARCELONA, Spain — All patients with systemic sclerosis (SSc) and mixed connective tissue disease (MCTD) should be screened for interstitial lung disease (ILD), according to new […]
June 14, 2025
BARCELONA, Spain — When to use apremilast and biologics such as adalimumab and infliximab and how to deal with vascular involvement are some of the main […]
June 14, 2025
MILAN — The landscape of hematologic malignancies is shifting rapidly, in part due to the evolving significance of measurable (formerly “minimal”) residual disease (MRD). Once confined […]
June 14, 2025
TOPLINE: Vasoactive vasodilating drugs (VVDs) have differential effects on the progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to a post hoc analysis of prospectively […]
FDA
June 13, 2025
Summary Company Announcement Date: March 27, 2023 FDA Publish Date: March 28, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Presence of […]
June 13, 2025
Docket Number: FDA-2017-D-3101 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of Pharmaceutical Quality The Food and Drug Administration (FDA or Agency) […]
June 12, 2025
On June 12, 2025, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for adults with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) […]
June 12, 2025
GDUFA III includes several enhancements to the abbreviated new drug application (ANDA) assessment process to maximize the efficiency and utility of each assessment cycle. These enhancements […]
